Delivery Order SPE2DB20D3103-SPE2DB25FM5P8

Award Date 2/3/25
Potential Completion Date 2/25/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,339.52, is for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a medication used in transplant patient care. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a $1,503.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through February 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,589.00, is for the supply of ENVARSUS XR 1 MG TABLET 30S, a specialty medication. The contract has a period of performance through February 13, 2025 and utilizes a Firm Fixed Price pricing type. This delivery order is issued under a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a specialty pharmaceutical product, with a potential value of $2,026.85 and a performance period through March 15, 2024. This delivery order is issued under a larger, single-award indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of ENVARSUS XR 4 MG TABLET 100S, a prescription medication, at a ceiling value of $10,059.86. The contract is a firm-fixed-price arrangement with an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a $1,465.68 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4566108782 - ENVARSUS XR 1 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical and medical supplies to support...
This federal contract award, worth $1,165.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with a completion date of February 26, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ENVARSUS XR 1 MG TABLET 100S. The contract has a completion date of March 8, 2024 and a potential value of $1,216.11. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This federal contract award, valued at $2,026.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENVARSUS XR 1 MG TABLET 30S. The order has a completion date of March 4, 2024 and a potential value of $1,465.68. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5P8
    Delivery Order

This is a $1,169.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a period of performance through February 25, 2025 and does not utilize any set-aside designations, indicating open competition.

Generated 5/5/25, 9:46 AM